Stock TEARLAB CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases TearLab Corp Nasdaq

Equities

US8781931014

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for TearLab Corp
2021 TearLab Corporation Announces Board Appointments CI
2021 TearLab Corporation Appoints Adam Szaronos as Chief Executive Officer CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
TEARLAB CORP : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
TearLab: 1Q Earnings Snapshot
AQ
TEARLAB : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
AQ
TEARLAB : Entry into a Material Definitive Agreement (form 8-K/A)
AQ
TEARLAB CORP : Entry into a Material Definitive Agreement (form 8-K)
AQ
TEARLAB CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
TEARLAB CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
TEARLAB CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
TEARLAB CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Unregistered Sale of Equity Securities, Changes in Control or Registrant, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
TearLab : Announces Acquisition By Accelmed Partners And Related $25 Million Investment
PR
TEARLAB CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
TearLab Corporation Confirms Merger Discussions
GL
TearLab Resubmits 510(k) for U.S. FDA Clearance of the TearLab Discovery™ MMP-9 Test
GL
TEARLAB CORP : Change in Directors or Principal Officers, Other Events (form 8-K)
AQ
TEARLAB CORP : Entry into a Material Definitive Agreement (form 8-K)
AQ
TEARLAB : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
TearLab: 4Q Earnings Snapshot
AQ
TearLab Corporation Reports Fourth Quarter and Full Year 2019 Financial Results
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. News TearLab Corp
  6. Press Releases